Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Rotarix Co-administered with Routine Infant Vaccines
NCT00334607Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Primary completion
- Feb 2007
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral in rotavirus infection, sponsored by GSK. Started Jun 2006; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00334607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334607.